Laduviglusib, CAS [[252917-06-9]]

Produktübersicht

• Artikelname: Laduviglusib, CAS [[252917-06-9]]
• Artikelnummer: MCE-HY-10182
• Hersteller Artikelnummer: HY-10182
• Alternativnummer: MCE-HY-10182-25MG,MCE-HY-10182-10MMX1ML,MCE-HY-10182-50MG,MCE-HY-10182-10MG,MCE-HY-10182-5MG,MCE-HY-10182-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: CHIR-99021, CT99021

Produktbeschreibung

Laduviglusib (CHIR-99021) is a potent, selective and orally active GSK-3alpha/beta inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/beta-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy[1][2][3].

Produkteigenschaften

• Molekulargewicht: 465.34
• Reinheit: 99.76
• CAS Nummer: [252917-06-9]
• Formel: C22H18Cl2N8
• Target-Kategorie: Autophagy,GSK-3,Organoid,Wnt,beta-catenin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound